An Introduction to Sarcomas
Sarcomas are a rare and diverse group of cancers that arise from the connective tissues of the body, such as bone, muscle, fat, cartilage, and blood vessels. They are broadly categorized into two main groups: soft tissue sarcomas and bone sarcomas. Their rarity, combined with the fact that there are over 70 different subtypes, makes them among the most challenging cancers to treat.
The treatment plan for a sarcoma is highly individualized and depends on a number of critical factors. These include the specific sarcoma subtype, the tumor’s grade (a measure of its aggressiveness), its size and location, whether it is a primary or recurrent tumor, and the patient’s age and overall health. For localized sarcomas, the goal of treatment is curative, typically centered around surgery. For sarcomas that have spread to other parts of the body (metastasized), the goal is to control the disease and manage symptoms.
The Critical Role of a Specialized Sarcoma Center
Due to their rarity and complexity, it is widely recognized that patients with a suspected or diagnosed sarcoma should be evaluated and treated at a specialized, high-volume center with a dedicated multidisciplinary team (MDT). An accurate diagnosis and an optimal treatment plan require a level of expertise that is concentrated in these centers.
The core members of a sarcoma MDT include:
- Surgical Oncologist or Orthopedic Oncologist: A surgeon with specific, extensive experience in removing sarcomas. The quality of the initial surgery is one of the most important factors in a successful outcome.
- Medical Oncologist: A physician who specializes in treating sarcomas with systemic medications like chemotherapy and targeted therapy.
- Radiation Oncologist: A physician who plans and delivers radiation therapy, a key component in the treatment of many sarcomas.
- Pathologist: A pathologist with expertise in sarcomas is crucial. The correct diagnosis of the specific subtype can be very difficult and dictates the entire treatment plan.
- Radiologist: A physician who specializes in interpreting MRI, CT, and PET scans to accurately stage the tumor and assess its relationship to surrounding structures.
- Rehabilitation Specialists: Physical and occupational therapists who are vital for restoring function, particularly after surgery on a limb.
The Importance of Diagnosis and Biopsy
The first step in treatment planning is obtaining a definitive diagnosis through a biopsy. The biopsy itself must be carefully planned and is often best performed by the surgical oncologist who will be doing the definitive surgery. A poorly placed biopsy can contaminate healthy tissue and may compromise the ability to perform limb-sparing surgery later. The pathologist’s review of the biopsy tissue to determine the exact subtype and grade of the sarcoma is arguably the most critical step in the entire process.
Surgical Treatment: The Cornerstone of Localized Sarcoma Care
For any sarcoma that is localized and has not spread, surgery is the primary and most important treatment modality. The overarching goal of the surgery is to achieve a “wide excision,” which means removing the entire tumor along with a surrounding margin of normal, healthy tissue. Achieving “negative margins” (meaning no cancer cells are found at the edge of the removed tissue) is critical to minimizing the risk of the cancer returning in the same location.
Limb-Sparing Surgery
For sarcomas that occur in an arm or a leg, the standard of care is limb-sparing (or limb-salvage) surgery. In the past, amputation was common. Today, a skilled surgeon can remove the tumor, along with any involved bone or muscle, while preserving the limb in the vast majority of cases. This often requires complex reconstruction, which may involve using a metal implant (prosthesis) to replace a segment of bone or using tissue flaps and skin grafts to rebuild soft tissue. The success of limb-sparing surgery almost always depends on a multi-modal approach, combining the surgery with radiation therapy.
Radiation Therapy in Sarcoma Management
Radiation therapy is a key partner to surgery in the treatment of many soft tissue sarcomas and some bone sarcomas. It uses high-energy beams to destroy cancer cells and is used to maximize local control of the tumor.
- For Soft Tissue Sarcomas: Radiation is most commonly used in combination with limb-sparing surgery. It significantly reduces the risk of the cancer recurring locally. It can be given in two ways:
- Neoadjuvant Radiation (Pre-operative): Radiation is delivered before surgery. This is an increasingly common approach. It can help shrink the tumor, may make it easier for the surgeon to achieve negative margins, and often involves treating a smaller, more targeted area.
- Adjuvant Radiation (Post-operative): Radiation is delivered after surgery. This is done to “sterilize” the surgical site and kill any microscopic cancer cells that may have been left behind.
- For Bone Sarcomas: The role of radiation is more varied. For osteosarcoma, it is used less frequently. However, for Ewing sarcoma, radiation is a very important part of treatment and can be used as the primary local therapy or after surgery.
Systemic Therapy: Chemotherapy and Targeted Therapy
Systemic therapies are medications that travel through the bloodstream to treat cancer cells throughout the body. Their role in sarcoma treatment is highly dependent on the specific subtype and stage.
Chemotherapy
Chemotherapy‘s role differs significantly between bone and soft tissue sarcomas.
- Bone Sarcomas: For high-grade bone sarcomas like osteosarcoma and Ewing sarcoma, chemotherapy is an essential, standard part of curative-intent treatment. It is almost always given both before surgery (neoadjuvant) to shrink the tumor and treat micrometastases, and after surgery (adjuvant) to kill any remaining cancer cells.
- Soft Tissue Sarcomas: The role of chemotherapy is less clear-cut and depends on the subtype and grade. For most low-grade soft tissue sarcomas, it is not used. For high-grade, large, deep tumors, adjuvant chemotherapy may be considered to reduce the risk of distant metastasis, though its benefit is debated for some subtypes. For sarcomas that have already metastasized, chemotherapy is a primary treatment.
Targeted Therapy
The development of targeted therapies has been a major advance for specific sarcoma subtypes that are driven by a known genetic mutation. These drugs work by blocking the specific proteins that tell the cancer cells to grow. The most well-known example is Gastrointestinal Stromal Tumor (GIST), a type of sarcoma for which targeted therapy drugs have dramatically improved outcomes. Other targeted therapies are available for other rare sarcoma subtypes.
Frequently Asked Questions
1. Why is it so important to be treated at a specialized sarcoma center?
Because sarcomas are so rare and diverse, their diagnosis and treatment require a high level of expertise. A specialized center has a multidisciplinary team, including pathologists and surgeons who see many sarcoma cases, which is critical for an accurate diagnosis and a successful surgical outcome. The experience of the entire team directly impacts the chances of a positive result.
2. What is the main goal of surgery for sarcoma?
The primary goal is a “wide local excision” with “negative margins.” This means the surgeon aims to remove the tumor in one piece, completely encased in a cuff of normal, healthy tissue. Achieving negative margins (no cancer cells at the edge of the specimen) is the most important factor in preventing the cancer from recurring in the same spot.
3. What is limb-sparing surgery?
Limb-sparing surgery is the standard surgical approach for most sarcomas located in an arm or leg. The surgeon removes the tumor and any involved tissues but preserves the basic function and appearance of the limb, avoiding the need for an amputation. This often involves complex reconstruction of bones and soft tissues.
4. Why is radiation therapy used so often for soft tissue sarcomas?
Even with excellent surgery, there can be a risk that microscopic cancer cells are left behind. Radiation therapy is used to kill these cells and sterilize the surgical area, which significantly reduces the risk of a local recurrence. Using radiation often allows the surgeon to perform a less extensive surgery while still achieving excellent local control.
5. Is chemotherapy a standard treatment for all sarcomas?
No. The role of chemotherapy is highly dependent on the sarcoma type. For high-grade bone sarcomas like osteosarcoma and Ewing sarcoma, it is a standard and essential part of treatment. For many low-grade soft tissue sarcomas, it is not used at all. For some high-grade soft tissue sarcomas, its use is considered on a case-by-case basis.
6. What is the most important first step after being told you might have a sarcoma?
The most important first step is to get an evaluation at a high-volume sarcoma center before any biopsy or surgery is performed, if at all possible. The planning of the initial biopsy and the first surgery are critical steps that have a major impact on the ultimate outcome, and they are best performed by a team that specializes in this rare disease.
7. How has targeted therapy changed sarcoma treatment?
Targeted therapy has been revolutionary for certain sarcoma subtypes. For Gastrointestinal Stromal Tumors (GIST), for example, targeted drugs that block a specific genetic mutation have turned a very difficult-to-treat cancer into a manageable disease for many patients. This highlights the growing importance of molecular testing to identify the specific drivers of different sarcoma subtypes.
